Nationwide Fund Advisors’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-56,901
Closed -$1.77M 2478
2017
Q3
$1.77M Buy
56,901
+2,377
+4% +$70.4K 0.01% 1499
2017
Q2
$1.52M Buy
54,524
+15,826
+41% +$358K 0.01% 1556
2017
Q1
$664K Buy
38,698
+3,134
+9% +$43.9K ﹤0.01% 1996
2016
Q4
$430K Hold
35,564
﹤0.01% 2253
2016
Q3
$563K Hold
35,564
﹤0.01% 2120
2016
Q2
$460K Sell
35,564
-135,925
-79% -$2.13M ﹤0.01% 2193
2016
Q1
$3.26M Sell
171,489
-26,998
-14% -$489K 0.01% 1135
2015
Q4
$4.47M Buy
198,487
+96,794
+95% +$1.91M 0.02% 978
2015
Q3
$2.38M Buy
101,693
+92,660
+1,026% +$2.56M 0.01% 1273
2015
Q2
$259K Buy
9,033
+4,688
+108% +$123K ﹤0.01% 2571
2015
Q1
$112K Sell
4,345
-58
-1% -$1.33K ﹤0.01% 2939
2014
Q4
$82K Sell
4,403
-1,792
-29% -$32.2K ﹤0.01% 2954
2014
Q3
$96K Buy
+6,195
New +$93.3K ﹤0.01% 2994

Other funds holding XENT

Nationwide Fund Advisors's XENT Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Intersect ENT, Inc (XENT) in Q4 2017, closing a stake of 56,901 shares — an estimated $1.77M sold.

Nationwide Fund Advisors first reported a position in XENT in Q3 2014 and held it in 13 quarters. The position peaked at $4.47M in Q4 2015. 157 funds tracked by Wall St. Rank hold XENT as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Intersect ENT, Inc position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 56,901 Intersect ENT, Inc shares in Q4 2017, an estimated $1.77M.
  • Nationwide Fund Advisors first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 13 quarters.
  • Nationwide Fund Advisors's Intersect ENT, Inc position peaked at $4.47M in Q4 2015.
  • 157 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.